Patni’s Steve Jolley, FDA’s Joseph Tonning to Present at Dec. 4 Webinar Hosted by the Drug Information Association; Experts Will Discuss Signal Detection, Case Assessment and Data Mining.
CAMBRIDGE, Mass. – December 3, 2008 -- Patni Computer Systems (BSE: PATNI COMPUT, NSE: PATNI, NYSE: PTI), a leading global IT and BPO services provider, today announced that Patni Life Sciences Vice President Steve Jolley will jointly conduct a webinar with a representative from the U.S. Food and Drug Administration on signal detection, case assessment and data mining in the current pharmacovigilance practices.
The webinar, hosted by the Drug Information Association (DIA), will take place on Thursday, Dec. 4, from 10 to 11:30 a.m. ET. The webinar is designed for clinical safety professionals involved in pharmacovigilance, pharmacoepidemiology, regulatory affairs, quality assurance, medical product safety assessment, and labeling.
Jolley, who heads the pharmacovigilance practice at Patni Life Sciences, and Joseph Tonning, from the FDA’s Office of Surveillance and Epidemiology, will present a theoretical and methodological review of the application of data mining techniques to safety surveillance, its application in signal detection, and the critical role of clinical case assessment.
“This is a great opportunity for clinical safety professionals to receive perspectives from the FDA and from private industry players about critical issues in pharmacovigilance,” Jolley said. “We look forward to participating in this valuable informational exercise.”
Details:
Webinar: “FDA and Industry Perspectives on Signal Detection and Data Mining”
Participants: Steve Jolley, Vice President, Pharmacovigilance, Patni Life Sciences; Joseph Tonning, MD, MPH, RPh, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration.
When: 10 to 11:30 a.m. ET, Thursday, December 4, 2008
Register: Visit www.diahome.org and enter keyword 08261
Cost: Standard DIA member ($250); standard nonmember ($295); full-time government ($125); full-time charitable nonprofit/academia ($175); group site ($799).
For more information about this webinar, contact Kathleen Donner at the DIA at 215-293-5810 or kathleen.donner@diahome.org.
About Patni
Patni Computer Systems Limited (BSE: PATNI COMPUT, NSE: PATNI, NYSE: PTI) is a global provider of IT Services and business solutions, servicing Global 2000 clients. Patni services its clients through its industry-focused practices, including banking, financial services and insurance (BFSI); manufacturing, retail and distribution (MRD); life sciences; communications, media and utilities (CMU), and its technology-focused practices.
With an employee strength of over 15,000; multiple global delivery centers spread across 11 cities worldwide; 23 international offices across the Americas, Europe and Asia-Pacific; Patni has registered revenues of US $663 million for the year 2007.
Patni’s service offerings include application development and maintenance, enterprise application solutions, business and technology consulting, product engineering services, infrastructure management services, customer interaction services & business process outsourcing, quality assurance and engineering services.
Committed to quality, Patni adds value to its clients' businesses through well-established and structured methodologies, tools and techniques. Patni is an ISO 9001: 2000 certified and SEI-CMMI Level 5 (V 1.2) organization, assessed enterprise wide at P-CMM Level 3. In keeping with its focus on continuous process improvements, Patni adopts Six Sigma practices as an integral part of its quality and process frameworks.
Patni leverages its vast experience spanning three decades; deep domain expertise; full-spectrum services; and suites of IP-led solutions, methodologies and frameworks; in being an effective business transformation partner to its clients.
For more information on Patni, visit www.patni.com.
About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA (USA), and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team.
For more information, visit www.diahome.org or call 215-442-6100.